title: Crohn's disease in common variable immunodeficiency: treatment with antitumor necrosis factor alpha.
authors.forename: Pilar
authors.initials: P
authors.lastname: Nos
authors.forename: Guillermo
authors.initials: G
authors.lastname: Bastida
authors.forename: Belen
authors.initials: B
authors.lastname: Beltran
authors.forename: Mariam
authors.initials: M
authors.lastname: Aguas
authors.forename: Julio
authors.initials: J
authors.lastname: Ponce
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017074:Common Variable Immunodeficiency / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003424:Crohn Disease / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab